1‐Methylnicotinamide (MNA), a primary metabolite of nicotinamide, exerts anti‐thrombotic activity mediated by a cyclooxygenase‐2/prostacyclin pathway
- 1 September 2007
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 152 (2), 230-239
- https://doi.org/10.1038/sj.bjp.0707383
Abstract
1-methylnicotinamide (MNA) has been considered to be an inactive metabolite of nicotinamide. Here we assessed the anti-thrombotic activity of MNA in vivo. Antithrombotic action of MNA was studied in normotensive rats with extracorporeal thrombus formation (thrombolysis), in renovascular hypertensive rats with intraarterial thrombus formation (arterial thrombosis) and in a venous thrombosis model in rats (venous thrombosis). MNA (3-100 mg kg(-1)) induced a dose-dependent and sustained thrombolytic response, associated with a rise in 6-keto-PGF(1alpha) in blood. Various compounds structurally related to MNA were either inactive or weaker thrombolytics. Rofecoxib (0.01-1 mg kg(-1)), dose-dependently inhibited the thrombolytic response of MNA, indomethacin (5 mg kg(-1)) abolished it, while L-NAME (5 mg kg(-1)) were without effect. MNA (3-30 mg kg(-1)) also reduced arterial thrombosis and this effect was abrogated by indomethacin (2.5 mg kg(-1)) as well as by rofecoxib (1 mg kg(-1)). MNA, however, did not affect venous thrombosis. In vitro MNA did not modify platelet aggregation nor induce vasodilation. MNA displayed a profile of anti-thrombotic activity in vivo that surpasses that of closely related compounds. MNA inhibited platelet-dependent thrombosis by a mechanism involving cyclooxygenase-2 and prostacyclin. Our findings suggest that endogenous MNA, produced in the liver by nicotinamide N-methyltransferase, could be an endogenous activator of prostacyclin production and thus may regulate thrombotic as well as inflammatory processes in the cardiovascular system.Keywords
This publication has 78 references indexed in Scilit:
- The Sorcerer II Global Ocean Sampling Expedition: Northwest Atlantic through Eastern Tropical PacificPLoS Biology, 2007
- The Sorcerer II Global Ocean Sampling Expedition: Expanding the Universe of Protein FamiliesPLoS Biology, 2007
- Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunitiesJCI Insight, 2005
- Topical application of 1-methylnicotinamide in the treatment of rosacea: a pilot studyClinical and Experimental Dermatology, 2005
- Metagenomic marine nitrogen fixation – feast or famine?Trends in Microbiology, 2005
- Advanced sequencing technologies: methods and goalsNature Reviews Genetics, 2004
- A Functional Link Between RuBisCO-like Protein of Bacillus and Photosynthetic RuBisCOScience, 2003
- Regulation of the vitamin B12 metabolism and transport in bacteria by a conserved RNA structural elementRNA, 2003
- An mRNA structure that controls gene expression by binding S-adenosylmethionineNature Structural & Molecular Biology, 2003
- Basic local alignment search toolJournal of Molecular Biology, 1990